logoTry Persana

Rosebud Biosciences - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Rosebud Biosciences including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Rosebud Biosciences company logo

Industrializing genetic disease models for drug discovery

Rosebud Biosciences develops therapies for genetic diseases by using organoids to model human disease.

HeadquartersSan Francisco Bay Area, United States
Team size2-10
Founded2020

What is Rosebud Biosciences? - Company Overview & Details

Rosebud Biosciences is Rosebud Biosciences develops therapies for genetic diseases by using organoids to model human disease. Founded in 2020, the company is headquartered in San Francisco Bay Area, United States.

Who Founded Rosebud Biosciences?

Rosebud Biosciences was founded by Kitch Wilson, Evan Lyall.

Who are the Key Executives at Rosebud Biosciences? - Leadership Team

Rosebud Biosciences is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Rosebud Biosciences

Kitch WilsonCEO

Chief Technology Officer (CTO) of Rosebud Biosciences

Evan LyallCTO

About Kitch Wilson - CEO of Rosebud Biosciences

Kitch Wilson serves as the Chief Executive Officer of Rosebud Biosciences, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Rosebud Biosciences Company Details & Key Information

Where is Rosebud Biosciences located?

Rosebud Biosciences is headquartered in San Francisco Bay Area, United States.

How many employees does Rosebud Biosciences have?

Rosebud Biosciences has 2-10 employees.

When was Rosebud Biosciences founded?

Rosebud Biosciences was founded in 2020.

Rosebud Biosciences Official Website

How much funding has Rosebud Biosciences raised?

Rosebud Biosciences has raised undisclosed amount across 2 funding rounds. The most recent funding was completed on 2022-04-29.

Funding Overview

Rosebud Biosciences has received a pre-seed funding from Y Combinator.

N/A
Total Funding Raised
2
Funding Rounds
2022-04-29
Latest Round

Rosebud Biosciences Funding History

Pre seed
2022-04-29
Series unknown
2022-04-29

Who are the key investors in Rosebud Biosciences?

Rosebud Biosciences is backed by 1 key investors including Y Combinator. These investors focus on Biotechnology, Pharmaceuticals sectors.

Rosebud Biosciences Investor Overview

1
Key Investors
2
Focus Areas
0
Notable Investments

Complete List of Rosebud Biosciences Investors

Y Combinator

A notable startup accelerator.

Investment Focus
Biotechnology
Pharmaceuticals

What sectors do Rosebud Biosciences investors focus on?

The investors backing Rosebud Biosciences primarily focus on Biotechnology, Pharmaceuticals sectors.

Biotechnology
Pharmaceuticals

Featured Investor: Y Combinator

Y Combinator

A notable startup accelerator.

Notable Investments:

What are Rosebud Biosciences's future plans?

Rosebud Biosciences Continuing to develop scalable models for drug discovery.

Rosebud Biosciences Strategic Outlook

Strategic Focus
Defined
1
Key Challenges
1
Growth Opportunities

What challenges does Rosebud Biosciences face?

Rosebud Biosciences has identified 1 key challenges that need to be addressed for continued growth and success.

Key Challenges for Rosebud Biosciences

1

High clinical trial failure rates

What opportunities does Rosebud Biosciences have?

Rosebud Biosciences has identified 1 key opportunities for growth and market expansion.

Growth Opportunities for Rosebud Biosciences

1

Advancements in organoid technology

Rosebud Biosciences Strategic Position Summary

Key Focus Areas

Rosebud Biosciences is addressing 1 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 1 key opportunities for expansion and growth.

What are the latest news about Rosebud Biosciences?

Rosebud Biosciences has 2 recent news updates covering key business developments and market activities.

Rosebud Biosciences News Overview

2
Recent Articles
Active
Media Coverage
2025-04-22
Latest Update

What is Rosebud Biosciences in the news for?

Rosebud Biosciences is currently featured in news for Can organoids completely replace mice in drug development? and other significant business developments.

Recent News Articles About Rosebud Biosciences

Article 1
2025-04-22

Can organoids completely replace mice in drug development?

Rosebud Biosciences discusses the potential of organoids in drug discovery amid high clinical trial failure rates.

LinkedIn
Read News
Article 2
2024-09-05

Pharma getting serious about noncoding RNAs

Rosebud Biosciences highlights the importance of noncoding RNAs for drug discovery.

Genetic Engineering & Biotechnology News
Read News

Rosebud Biosciences FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Rosebud Biosciences including information about founders, CEO, funding history, investors, headquarters location, and company details. 17 frequently asked questions covering key information about the company.

Rosebud Biosciences Questions & Answers - Company Information

Q1

What is Rosebud Biosciences?

Rosebud Biosciences develops therapies for genetic diseases by using organoids to model human disease.

Q2

Who founded Rosebud Biosciences?

Rosebud Biosciences was founded by Kitch Wilson, Evan Lyall.

Q3

Who is the CEO of Rosebud Biosciences?

The CEO of Rosebud Biosciences is Kitch Wilson. You can find more information about them on their LinkedIn profile.

Q4

Who are the investors in Rosebud Biosciences?

Rosebud Biosciences's key investors include Y Combinator.

Q5

Where is Rosebud Biosciences headquartered?

Rosebud Biosciences is headquartered in San Francisco Bay Area, United States.

Q6

When was Rosebud Biosciences founded?

Rosebud Biosciences was founded in 2020.

Q7

How many employees does Rosebud Biosciences have?

Rosebud Biosciences has 2-10 employees.

Q8

What is Rosebud Biosciences's official website?

You can visit Rosebud Biosciences's official website at http://www.rosebudbiosciences.com.

Q9

What was Rosebud Biosciences's latest funding round?

Rosebud Biosciences's latest funding round was a Pre seed round completed on 2022-04-29.

Q10

Who is founder?

Kitch Wilson

Q11

Who is cto?

Evan Lyall

Q12

What does the company do?

Rosebud Biosciences develops therapies for genetic diseases using organoids to model human disease.

Q13

Latest funding date?

2022-04-29

Q14

Who are the investors?

Y Combinator

Q15

What are the challenges?

High clinical trial failure rates

Q16

What are the opportunities?

Advancements in organoid technology

Q17

Latest news?

Rosebud Biosciences discusses the potential of organoids in drug discovery amid high clinical trial failure rates. Rosebud Biosciences highlights the importance of noncoding RNAs for drug discovery.

More Information About Rosebud Biosciences

For additional details about Rosebud Biosciences, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.